Tiziana Life Sciences Ltd Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019
Tiziana Life Sciences Ltd (TLSA) reported Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 of $61.00 per share for the 12-month period ending 2023-12-31, per its 20-F filed 2024-05-10.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 · last filed 2024-05-10
- 2020-06-01: Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 0 month 0.70 GBP/shares.
GBP/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 0 month |
|---|---|
| 2020-06-01 | 0.70 GBP/shares 20-F · filed 2021-05-17 |
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Granted In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2023-12-31 | $61.00 20-F · filed 2024-05-10 |
| 2022-12-31 | $69.00 20-F · filed 2024-05-10 |
| 2021-12-31 | $166.00 20-F · filed 2022-05-23 |
| 2020-12-31 | $111.00 20-F · filed 2022-05-23 |
| 2018-12-31 | $104.00 20-F · filed 2021-05-17 |
| 2017-12-31 | $216.00 20-F · filed 2020-06-17 |